BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 579101)

  • 1. [Studies on the influence of the antihypertensive drug urapidil on blood circulation and its regulation in animal experiments (author's transl)].
    Schoetensack W; Bischler P; Dittmann EC; Steinijans V
    Arzneimittelforschung; 1977; 27(10):1908-19. PubMed ID: 579101
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic studies on hypertension. II. Effects of isoproterenol, propranolol, noradrenaline and phentolamine on the hemodynamics in essential hypertension.
    Tsuchiya M
    Jpn Circ J; 1972 Mar; 36(3):275-88. PubMed ID: 5068095
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the hypotensive action of prazosin.
    Constantine JW; McShane WK; Scriabine A; Hess HJ
    Postgrad Med; 1975 Nov; Spec No():18-35. PubMed ID: 1197141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanics of circulation in lowering the blood pressure in different hemodynamic forms of hypertension (author's transl)].
    Schäfer N; Härich BK; Hansen B; Stauch M
    Med Klin; 1976 Jan; 71(5):205-12. PubMed ID: 814397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of infused norepinephrine in dogs on cardiopulmonary bypass.
    Kirkendol PL; Woodbury RA
    J Pharmacol Exp Ther; 1972 May; 181(2):369-76. PubMed ID: 5030677
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)].
    Levenson J; Simon A; Temmar M; Safar M
    Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive drugs: proposed sites and mechanisms of action.
    Kaplan HR; Smith RD
    Fed Proc; 1981 Jun; 40(8):2268-74. PubMed ID: 6113170
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies relating to the antihypertensive and antidysrhythmic action of indoramin.
    Baum T; Shropshire AT; Eckfeld DK; Metz N; Dinish JL; Peters JR; Butz F; Gluckman MI
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):390-406. PubMed ID: 4356047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Depressive effect of total flavonoid fraction of Asttragalus complanatus R. Br and its influence upon hemodynamics in SHR].
    Xue B; Li JX; Chen LB
    Zhongguo Zhong Yao Za Zhi; 2002 Nov; 27(11):855-8. PubMed ID: 12776592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the mechanism of action of aminorexfumarate (author's transl)].
    Schuster J
    Arzneimittelforschung; 1975 Oct; 25(10):1574-81. PubMed ID: 1243041
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the effect of urapidil on the central nervous system and various organ functions in animal experiments (author's transl)].
    Schoetensack W; Eltze M; Gönne S; Kley KP; Menge HG; Müller H
    Arzneimittelforschung; 1977; 27(10):1898-907. PubMed ID: 579100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
    Hayashi N; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of cardiovascular effect of neuroleptanesthesia (Part I)--cardiovascular effect of pentazocine (author's transl)].
    Sone T
    Masui; 1980 Mar; 29(3):225-31. PubMed ID: 7373840
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurogenic maintenance of peripheral resistance in borderline hypertension.
    Julius S; Esler M; Randall OS; Ellis C
    Acta Physiol Lat Am; 1974; 24(5):425-31. PubMed ID: 4467668
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of regitine haemodynamics of pulmonary circulation in pulmonary hypertension in man.
    Horzela T; Dubiel JP; Dubiel JS; Pyzik Z; Szczeklik J
    Acta Physiol Pol; 1974 May; 25(3):241-9. PubMed ID: 4842545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.